These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31064654)

  • 21. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice.
    Yu D; Chen G; Pan M; Zhang J; He W; Liu Y; Nian X; Sheng L; Xu B
    J Cell Physiol; 2018 Jun; 233(6):4770-4782. PubMed ID: 29150932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-salt in addition to high-fat diet may enhance inflammation and fibrosis in liver steatosis induced by oxidative stress and dyslipidemia in mice.
    Uetake Y; Ikeda H; Irie R; Tejima K; Matsui H; Ogura S; Wang H; Mu S; Hirohama D; Ando K; Sawamura T; Yatomi Y; Fujita T; Shimosawa T
    Lipids Health Dis; 2015 Feb; 14():6. PubMed ID: 25888871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JIP3 knockout protects mice against high fat diet-induced liver injury.
    Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
    Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IDH2 Deficiency Is Critical in Myogenesis and Fatty Acid Metabolism in Mice Skeletal Muscle.
    Pan JH; Tang J; Kim YJ; Lee JH; Shin EC; Zhao J; Kim KH; Hwang KA; Huang Y; Kim JK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
    Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice.
    Moro T; Nakao S; Sumiyoshi H; Ishii T; Miyazawa M; Ishii N; Sato T; Iida Y; Okada Y; Tanaka M; Hayashi H; Ueha S; Matsushima K; Inagaki Y
    PLoS One; 2016; 11(1):e0146592. PubMed ID: 26745268
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Park JH; Ku HJ; Lee JH; Park JW
    Oxid Med Cell Longev; 2017; 2017():1595103. PubMed ID: 29456784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
    Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
    Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.
    Lee HJ; Yeon JE; Ko EJ; Yoon EL; Suh SJ; Kang K; Kim HR; Kang SH; Yoo YJ; Je J; Lee BJ; Kim JH; Seo YS; Yim HJ; Byun KS
    World J Gastroenterol; 2015 Dec; 21(45):12787-99. PubMed ID: 26668503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
    Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
    World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING.
    Li YN; Su Y
    Biochem Biophys Res Commun; 2020 May; 526(2):381-388. PubMed ID: 32223926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis.
    Gao L; Wang PX; Zhang Y; Yu CJ; Ji Y; Wang X; Zhang P; Jiang X; Jin H; Huang Z; Zhang ZR; Li H
    J Hepatol; 2016 Jul; 65(1):125-136. PubMed ID: 27032381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
    Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
    Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial NADP
    Kong MJ; Han SJ; Kim JI; Park JW; Park KM
    Cell Death Dis; 2018 May; 9(5):488. PubMed ID: 29695796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertrophic preconditioning attenuates post-myocardial infarction injury through deacetylation of isocitrate dehydrogenase 2.
    Ma LL; Kong FJ; Ma YJ; Guo JJ; Wang SJ; Dong Z; Sun AJ; Zou YZ; Ge JB
    Acta Pharmacol Sin; 2021 Dec; 42(12):2004-2015. PubMed ID: 34163022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isocitrate dehydrogenase 2 deficiency induces endothelial inflammation via p66sh-mediated mitochondrial oxidative stress.
    Choi SJ; Piao S; Nagar H; Jung SB; Kim S; Lee I; Kim SM; Song HJ; Shin N; Kim DW; Irani K; Jeon BH; Park JW; Kim CS
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1805-1811. PubMed ID: 30072100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transmembrane protein 126B protects against high fat diet (HFD)-induced renal injury by suppressing dyslipidemia via inhibition of ROS.
    Weihong C; Bin C; Jianfeng Y
    Biochem Biophys Res Commun; 2019 Jan; 509(1):40-47. PubMed ID: 30580996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.
    Ye P; Liu J; Xu W; Liu D; Ding X; Le S; Zhang H; Chen S; Chen M; Xia J
    Hepatology; 2019 May; 69(5):1946-1964. PubMed ID: 30582764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.